| |
EXP Group
|
CTRL Group
|
Statistics
|
|---|
|
mean ± SD
|
mean ± SD
|
Baseline
|
|---|
|
Gender (M/F)
|
7/3
|
5/3
| |
|
Age (yr)
|
69.18 ± 7.61
|
63.37 ± 6.89
|
p = 0.24
|
|
Height (cm)
|
160.91 ± 9.58
|
160.62 ± 14.74
|
p = 0.96
|
|
Weight (kg)
|
69.54 ± 13.33
|
67.62 ± 8.31
|
p = 0.72
|
|
Disease duration (yr)
|
7.82 ± 4.00
|
8.12 ± 2.90
|
p = 0.86
|
|
Falls (n)
|
1.45 ± 2.16
|
0.87 ± 0.99
|
p = 0.07
|
|
Levodopa (mg/day)
|
455.32 ± 355.49
|
409.19 ± 340.68
|
p = 0.74
|
|
• Dopamine agonist (LEDD mg)
|
|
Pramipexole E.R.
|
n = 2
|
n = 3
|
N.A.
|
|
Ropirinole E.R.
|
n = 3
|
n = 3
|
N.A.
|
|
Rotigotine (n = 1)
|
n = 1
|
n = 1
|
N.A.
|
|
Rasagiline (n = 1)
|
n = 2
|
n = 1
|
N.A.
|
|
• Other drugs (LEDD mg)
|
|
Entacapone
|
n = 1
|
n = 2
|
N.A.
|
|
Selegiline
|
n = 1
|
n = 2
|
N.A.
|
|
Amantadine
|
n = 2
|
n = 2
|
N.A.
|
- Exp, Experimental; CTRL, Control; M, Male; F, Female; Yr, Years; Cm, centimeters; Kg, Kilograms; Mg = Milligrams; N, number; ER = Extended Released; N.A., Not Applicable
